Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer

Condition:   Esophageal Cancer
Intervention:   Drug: S-1 and Oxaliplatin
Sponsors:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Celgene Corporation
Recruiting - verified July 2016

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2ah2DHJ
via IFTTT